{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:42:26Z","timestamp":1790109746550,"version":"4.0.1"},"reference-count":237,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","id.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.idc.2016.02.003","type":"journal-article","created":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T04:58:48Z","timestamp":1463633928000},"page":"347-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["The Continuing Plague of Extended-spectrum \u03b2-lactamase\u2013producing Enterobacteriaceae Infections"],"prefix":"10.1016","volume":"30","author":[{"given":"Amos","family":"Adler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dror","family":"Marchaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2016.02.003_bib2","doi-asserted-by":"crossref","first-page":"i29","DOI":"10.1093\/jac\/dkp255","article-title":"Has the era of untreatable infections arrived?","volume":"64","author":"Livermore","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.idc.2016.02.003_bib3","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ajic.2011.10.013","article-title":"\u201cSwimming in resistance\u201d: co-colonization with carbapenem-resistant enterobacteriaceae and Acinetobacter baumannii or pseudomonas aeruginosa","volume":"40","author":"Marchaim","year":"2012","journal-title":"Am J Infect Control"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s15010-009-8460-5","article-title":"Urinary tract infections caused by multi-drug resistant Proteus mirabilis: risk factors and clinical outcomes","volume":"38","author":"Cohen-Nahum","year":"2010","journal-title":"Infection"},{"issue":"7","key":"10.1016\/j.idc.2016.02.003_bib5","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1128\/AAC.49.7.2598-2605.2005","article-title":"Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases","volume":"49","author":"Endimiani","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.idc.2016.02.003_bib6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s10096-008-0545-z","article-title":"Epidemiology of bacteremia episodes in a single center: increase in gram-negative isolates, antibiotics resistance, and patient age","volume":"27","author":"Marchaim","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2016.02.003_bib7","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2217\/fmb.13.73","article-title":"The role of antimicrobial stewardship in curbing carbapenem resistance","volume":"8","author":"Bogan","year":"2013","journal-title":"Future Microbiol"},{"key":"10.1016\/j.idc.2016.02.003_bib8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2217\/fmb.15.16","article-title":"The complex epidemiology of extended-spectrum beta-lactamase-producing enterobacteriaceae","volume":"10","author":"Tal Jasper","year":"2015","journal-title":"Future Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1586\/14787210.6.5.549","article-title":"Importance of antibiotic resistance and resistance mechanisms. Foreword","volume":"6","author":"Bonomo","year":"2008","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2016.02.003_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1469-0691.2007.01864.x","article-title":"Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing enterobacteriaceae: the role of piperacillin-tazobactam","volume":"14","author":"Peterson","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idc.2016.02.003_bib12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-micro-090110-102911","article-title":"Epidemiological expansion, structural studies, and clinical challenges of new beta-lactamases from gram-negative bacteria","volume":"65","author":"Bush","year":"2011","journal-title":"Annu Rev Microbiol"},{"issue":"12","key":"10.1016\/j.idc.2016.02.003_bib13","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1086\/673982","article-title":"Identifying targets for antimicrobial stewardship in children's hospitals","volume":"34","author":"Gerber","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"19","key":"10.1016\/j.idc.2016.02.003_bib14","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1056\/NEJMra0904124","article-title":"Hospital-acquired infections due to gram-negative bacteria","volume":"362","author":"Peleg","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib15","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1128\/AAC.05913-11","article-title":"Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-beta-lactamase-producing enterobacteriaceae","volume":"56","author":"Collins","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib16","first-page":"677","article-title":"An enzyme from bacteria able to destroy penicillin. 1940","volume":"10","author":"Abraham","year":"1988","journal-title":"Rev Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib17","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","article-title":"Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat","volume":"14","author":"Bradford","year":"2001","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2016.02.003_bib18","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/clinids\/24.Supplement_1.S19","article-title":"Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics","volume":"24","author":"Medeiros","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMra041359","article-title":"The new beta-lactamases","volume":"352","author":"Jacoby","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.idc.2016.02.003_bib20","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/AAC.39.6.1211","article-title":"A\u00a0functional classification scheme for beta-lactamases and its correlation with molecular structure","volume":"39","author":"Bush","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.idc.2016.02.003_bib21","doi-asserted-by":"crossref","first-page":"6220","DOI":"10.1128\/JCM.43.12.6220.2005","article-title":"Beta-lactamase nomenclature","volume":"43","author":"Jacoby","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"issue":"7","key":"10.1016\/j.idc.2016.02.003_bib22","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1128\/AAC.05419-11","article-title":"Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli","volume":"56","author":"Chopra","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.idc.2016.02.003_bib23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/666632","article-title":"Extended-spectrum beta-lactamase producers reported as susceptible to piperacillin-tazobactam, cefepime, and cefuroxime in the era of lowered breakpoints and no confirmatory tests","volume":"33","author":"Marchaim","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2016.02.003_bib24","series-title":"Nineteenth informational supplement. Approved standard m100\u2013s19","article-title":"Performance standards for\u00a0antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2009"},{"issue":"6","key":"10.1016\/j.idc.2016.02.003_bib25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1055\/s-2007-996411","article-title":"Optimizing therapy for infections caused by enterobacteriaceae producing extended-spectrum beta-lactamases","volume":"28","author":"Endimiani","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib26","doi-asserted-by":"crossref","first-page":"c58","DOI":"10.1159\/000086223","article-title":"Serious consequences to the use of cephalosporins as the first line of antimicrobial therapy administered in hemodialysis units","volume":"101","author":"Marchaim","year":"2005","journal-title":"Nephron Clin Pract"},{"issue":"7","key":"10.1016\/j.idc.2016.02.003_bib27","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1086\/500936","article-title":"Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital","volume":"42","author":"Ben-Ami","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2016.02.003_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum beta-lactamase-producing enterobacteriaceae: an emerging public-health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2016.02.003_bib29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ja.2013.56","article-title":"Fosfomycin activity versus carbapenem-resistant enterobacteriaceae and vancomycin-resistant enterococcus, Detroit, 2008-10","volume":"66","author":"Pogue","year":"2013","journal-title":"J\u00a0Antibiot (Tokyo)"},{"issue":"12","key":"10.1016\/j.idc.2016.02.003_bib30","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1128\/AAC.00565-10","article-title":"National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by enterobacteriaceae producing extended-spectrum beta-lactamases","volume":"54","author":"Marchaim","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib31","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/jac\/dkm310","article-title":"Antimicrobial susceptibility among organisms from the Asia\/Pacific rim, Europe and Latin and North America collected as part of test and the in\u00a0vitro activity of tigecycline","volume":"60","author":"Reinert","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/00365540903244543","article-title":"In\u00a0vitro activity of tigecycline and comparators against a European compilation of anaerobes collected as part of the tigecycline evaluation and surveillance trial (test)","volume":"42","author":"Nagy","year":"2010","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-8579(02)00249-2","article-title":"Sustained activity and spectrum of selected extended-spectrum beta-lactams (carbapenems and cefepime) against Enterobacter spp. And ESBL-producing Klebsiella spp.: report from the sentry antimicrobial surveillance program (USA, 1997-2000)","volume":"21","author":"Jones","year":"2003","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijantimicag.2008.07.031","article-title":"Comparative in\u00a0vitro activity of tigecycline and other antimicrobials against gram-negative and gram-positive organisms collected from the asia-pacific rim as part of the tigecycline evaluation and surveillance trial (test)","volume":"33","author":"Bouchillon","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1469-0691.2007.01943.x","article-title":"Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial","volume":"14","author":"Rodloff","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.idc.2016.02.003_bib36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.diagmicrobio.2005.06.001","article-title":"In\u00a0vitro activity of tigecycline against 6792 gram-negative and gram-positive clinical isolates from the global tigecycline evaluation and surveillance trial (test program, 2004)","volume":"52","author":"Hoban","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2016.02.003_bib37","doi-asserted-by":"crossref","first-page":"569.e1","DOI":"10.1016\/j.cmi.2015.02.012","article-title":"Antibiotic resistance patterns of more than 120 000 clinical Escherichia coli isolates in southeast Austria, 1998-2013","volume":"21","author":"Badura","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idc.2016.02.003_bib38","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2217\/fmb.15.22","article-title":"The changing epidemiology of hospital outbreaks due to ESBL-producing Klebsiella pneumoniae: the ctx-m-15 type consolidation","volume":"10","author":"Calbo","year":"2015","journal-title":"Future Microbiol"},{"key":"10.1016\/j.idc.2016.02.003_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12941-015-0088-y","article-title":"Simple bedside score to optimize the time and the decision to initiate appropriate therapy for carbapenem-resistant enterobacteriaceae","volume":"14","author":"Leibman","year":"2015","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib40","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3904\/kjim.2012.27.2.128","article-title":"Current epidemiology and growing resistance of gram-negative pathogens","volume":"27","author":"Livermore","year":"2012","journal-title":"Korean J Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2016.02.003_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1469-0691.2007.01857.x","article-title":"Defining an extended-spectrum beta-lactamase","volume":"14","author":"Livermore","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"8336","key":"10.1016\/j.idc.2016.02.003_bib43","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0140-6736(83)92696-X","article-title":"Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children","volume":"1","author":"del Rio","year":"1983","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2016.02.003_bib44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000238033","article-title":"Ceftriaxone, a new parenteral cephalosporin, in the treatment of urinary tract infections","volume":"27","author":"Bernstein Hahn","year":"1981","journal-title":"Chemotherapy"},{"issue":"7 Pt 1","key":"10.1016\/j.idc.2016.02.003_bib45","first-page":"584","volume":"119","year":"1993","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib46","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/AAC.28.2.302","article-title":"Evolution of plasmid-coded resistance to broad-spectrum cephalosporins","volume":"28","author":"Kliebe","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2016.02.003_bib47","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1469-0691.2007.01848.x","article-title":"Extended-spectrum beta-lactamases in North America, 1987-2006","volume":"14","author":"Bush","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib48","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jhin.2009.02.021","article-title":"Extended-spectrum beta-lactamase-producing organisms","volume":"73","author":"Falagas","year":"2009","journal-title":"J\u00a0Hosp Infect"},{"issue":"8554","key":"10.1016\/j.idc.2016.02.003_bib49","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0140-6736(87)90891-9","article-title":"Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae","volume":"2","author":"Brun-Buisson","year":"1987","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/jac\/45.2.183","article-title":"Antimicrobial resistance amongst Klebsiella spp. Collected from intensive care units in southern and western Europe in 1997-1998","volume":"45","author":"Babini","year":"2000","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.idc.2016.02.003_bib51","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/jac\/38.3.409","article-title":"Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. From intensive care units in Europe","volume":"38","author":"Livermore","year":"1996","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib52","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1086\/514938","article-title":"Clinical and bacteriologic epidemiology of extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit","volume":"27","author":"Decre","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/jac\/dki166","article-title":"Emergence of enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community","volume":"56","author":"Pitout","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib54","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.mib.2006.08.011","article-title":"The ctx-m beta-lactamase pandemic","volume":"9","author":"Canton","year":"2006","journal-title":"Curr Opin Microbiol"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0195-6701(96)90011-0","article-title":"An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland","volume":"33","author":"Hobson","year":"1996","journal-title":"J\u00a0Hosp Infect"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib56","first-page":"CR44","article-title":"Extended-spectrum beta-lactamase-producing enterobacteriaceae strains in community-acquired bacteremia in southern Israel","volume":"8","author":"Borer","year":"2002","journal-title":"Med Sci Monit"},{"issue":"11","key":"10.1016\/j.idc.2016.02.003_bib57","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1128\/AAC.39.11.2516","article-title":"Resistance to ceftriaxone and other beta-lactams in bacteria isolated in the community. The vigil'roc study group","volume":"39","author":"Goldstein","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib58","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1128\/JCM.43.2.745-749.2005","article-title":"High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania","volume":"43","author":"Blomberg","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"issue":"8","key":"10.1016\/j.idc.2016.02.003_bib59","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3201\/eid0908.030094","article-title":"Community transmission of extended-spectrum beta-lactamase","volume":"9","author":"Mirelis","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2016.02.003_bib60","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1086\/421094","article-title":"Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blactx-m genes","volume":"38","author":"Pitout","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib61","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/jac\/dkl435","article-title":"Molecular epidemiology of multiresistant Escherichia coli isolates from community-onset urinary tract infections in Cornwall, England","volume":"59","author":"Woodford","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib62","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0732-8893(98)00113-8","article-title":"Extended spectrum beta-lactamase production and fluorquinolone resistance in pathogens associated with community acquired urinary tract infection","volume":"32","author":"Cormican","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib63","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s100960050440","article-title":"Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre study group","volume":"19","author":"Goldstein","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"51\u201352","key":"10.1016\/j.idc.2016.02.003_bib64","first-page":"1167","article-title":"Laboratory capacity to detect antimicrobial resistance, 1998","volume":"48","author":"Centers for Disease Control and Prevention (CDC)","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.idc.2016.02.003_bib65","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1086\/600391","article-title":"Long-term acute care hospitals","volume":"49","author":"Munoz-Price","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"16","key":"10.1016\/j.idc.2016.02.003_bib66","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1001\/jama.267.16.2245","article-title":"Fluid intake and urinary tract infection in the elderly","volume":"267","author":"Denman","year":"1992","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.idc.2016.02.003_bib67","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1086\/652760","article-title":"The pivotal role of long-term care facilities in the epidemiology of Acinetobacter baumannii: another brick in the wall","volume":"50","author":"de Medina","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2016.02.003_bib68","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.ajic.2011.09.011","article-title":"The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities","volume":"40","author":"Marchaim","year":"2012","journal-title":"Am J Infect Control"},{"issue":"12","key":"10.1016\/j.idc.2016.02.003_bib69","doi-asserted-by":"crossref","first-page":"E497","DOI":"10.1111\/j.1469-0691.2012.03999.x","article-title":"Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre","volume":"18","author":"Adler","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.idc.2016.02.003_bib70","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1086\/652759","article-title":"Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes","volume":"50","author":"Sengstock","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib71","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/604713","article-title":"A\u00a0multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients","volume":"49","author":"Ben-Ami","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1016\/j.idc.2016.02.003_bib72","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/archinte.168.17.1897","article-title":"Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli","volume":"168","author":"Rodriguez-Bano","year":"2008","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib73","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/jac\/dkn293","article-title":"Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology","volume":"62","author":"Rodriguez-Bano","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.idc.2016.02.003_bib74","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1086\/500945","article-title":"A\u00a0change in the epidemiology of infections due to extended-spectrum beta-lactamase-producing organisms","volume":"42","author":"Rodriguez-Bano","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib75","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/cid\/cis942","article-title":"Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the united states","volume":"56","author":"Doi","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2016.02.003_bib76","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1128\/AAC.02516-12","article-title":"Epidemiology and risk factors for isolation of Escherichia coli producing ctx-m-type extended-spectrum beta-lactamase in a large U.S. Medical center","volume":"57","author":"Hayakawa","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2016.02.003_bib77","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrmicro1614","article-title":"The antibiotic resistome: the nexus of chemical and genetic diversity","volume":"5","author":"Wright","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib78","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1469-0691.2007.01884.x","article-title":"Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli","volume":"14","author":"Rodriguez-Bano","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib79","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1128\/AAC.50.4.1257-1262.2006","article-title":"Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing enterobacteriaceae","volume":"50","author":"Schwaber","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib80","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/AAC.49.5.2137-2139.2005","article-title":"High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing enterobacteriaceae","volume":"49","author":"Schwaber","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib81","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkm318","article-title":"Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in enterobacteriaceae bacteraemia: a systematic review and meta-analysis","volume":"60","author":"Schwaber","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.idc.2016.02.003_bib82","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1086\/591864","article-title":"Clinical and molecular epidemiology of healthcare-associated infections due to extended-spectrum beta-lactamase (ESBL)-producing strains of Escherichia coli and Klebsiella pneumoniae that harbor multiple ESBL genes","volume":"29","author":"Apisarnthanarak","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.idc.2016.02.003_bib83","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1128\/AAC.01320-07","article-title":"Escherichia coli isolate coproducing 16s rRNA methylase and ctx-m-type extended-spectrum beta-lactamase isolated from an outpatient in the united states","volume":"52","author":"Doi","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib84","first-page":"599","article-title":"Faecal carriage of ctx-m-15-producing Klebsiella pneumoniae in patients with acute gastroenteritis","volume":"129","author":"Doi","year":"2009","journal-title":"Indian J Med Res"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib85","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1469-0691.2009.03001.x","article-title":"Extended-spectrum and cmy-type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain","volume":"16","author":"Doi","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.idc.2016.02.003_bib86","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/jac\/dki239","article-title":"Ctx-m: changing the face of ESBLs in the UK","volume":"56","author":"Livermore","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.idc.2016.02.003_bib87","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/jac\/dkt212","article-title":"Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream enterobacteriaceae from the UK: links to prescribing change?","volume":"68","author":"Livermore","year":"2013","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.idc.2016.02.003_bib88","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00001432-200112000-00006","article-title":"Extended-spectrum beta-lactamases: the European experience","volume":"14","author":"Paterson","year":"2001","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib89","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1128\/AAC.02622-12","article-title":"Extended-spectrum beta-lactamase ctx-m-15-producing Klebsiella pneumoniae of sequence type st274 in companion animals","volume":"57","author":"Poirel","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.idc.2016.02.003_bib90","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/jac\/dkp108","article-title":"Nationwide survey of extended-spectrum {beta}-lactamase-producing enterobacteriaceae in the French community setting","volume":"63","author":"Arpin","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib91","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1128\/AAC.01656-10","article-title":"Ctx-m-93, a ctx-m variant lacking penicillin hydrolytic activity","volume":"55","author":"Djamdjian","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib92","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF01647010","article-title":"A\u00a0new plasmidic cefotaximase in a clinical isolate of Escherichia coli","volume":"18","author":"Bauernfeind","year":"1990","journal-title":"Infection"},{"key":"10.1016\/j.idc.2016.02.003_bib93","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fmicb.2012.00110","article-title":"Ctx-m enzymes: origin and diffusion","volume":"3","author":"Canton","year":"2012","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.48.1.1-14.2004","article-title":"Growing group of extended-spectrum beta-lactamases: the ctx-m enzymes","volume":"48","author":"Bonnet","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib95","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jac\/dkn182","article-title":"Dissemination of the ctx-m-25 family beta-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme ctx-m-41 in Proteus mirabilis in Israel","volume":"62","author":"Navon-Venezia","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6\u20137","key":"10.1016\/j.idc.2016.02.003_bib96","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/00365540903582434","article-title":"A\u00a0case-control study of risk factors for urinary acquisition of Klebsiella pneumoniae producing ctx-m-15 in an outbreak situation in Sweden","volume":"42","author":"Lytsy","year":"2010","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib97","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1469-0691.2009.02941.x","article-title":"Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections","volume":"16","author":"Azap","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.idc.2016.02.003_bib98","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ajic.2007.05.008","article-title":"Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study","volume":"35","author":"Apisarnthanarak","year":"2007","journal-title":"Am J Infect Control"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib99","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/jac\/dkl035","article-title":"Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases","volume":"57","author":"Calbo","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1086\/498519","article-title":"Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control","volume":"42","author":"Rodriguez-Bano","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2016.02.003_bib101","unstructured":"Association AU. Best practice policy statement on urologic surgery antimicrobial prophylaxis. 2011."},{"key":"10.1016\/j.idc.2016.02.003_bib102","unstructured":"Urology EAo. Guidelines on urological infections; 2013."},{"issue":"Suppl 1","key":"10.1016\/j.idc.2016.02.003_bib103","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1086\/591066","article-title":"Strategies to prevent catheter-associated urinary tract infections in acute care hospitals","volume":"29","author":"Lo","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib104","first-page":"1379","article-title":"Best practice policy statement on urologic surgery antimicrobial prophylaxis","volume":"179","author":"Wolf","year":"2008","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00345-011-0722-z","article-title":"Preoperative assessment of the patient and risk factors for infectious complications and tentative classification of surgical field contamination of urological procedures","volume":"30","author":"Grabe","year":"2012","journal-title":"World J Urol"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib106","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1590\/0074-02760140389","article-title":"Widespread distribution of ctx-m and plasmid-mediated AmpC beta-lactamases in Escherichia coli from Brazilian chicken meat","volume":"110","author":"Botelho","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.idc.2016.02.003_bib107","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijfoodmicro.2015.06.026","article-title":"Virulence and antimicrobial resistance determinants of verotoxigenic Escherichia coli (VTEC) and of multidrug-resistant E. Coli from foods of animal origin illegally imported to the EU by flight passengers","volume":"209","author":"Nagy","year":"2015","journal-title":"Int J Food Microbiol"},{"issue":"8","key":"10.1016\/j.idc.2016.02.003_bib108","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1128\/AAC.00775-15","article-title":"Dissemination of inci2 plasmids that harbor the blactx-m element among clinical salmonella isolates","volume":"59","author":"Wong","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib109","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.4315\/0362-028X.JFP-14-490","article-title":"Characterization of extended-spectrum beta-lactamase-producing Escherichia coli strains isolated from retail foods in Shaanxi Province, China","volume":"78","author":"Xi","year":"2015","journal-title":"J\u00a0Food Prot"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/10408398.2010.519837","article-title":"Antibiotic-resistant bacteria: a challenge for the food industry","volume":"53","author":"Capita","year":"2013","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib111","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/1040841X.2012.691458","article-title":"Antimicrobial resistance of emerging foodborne pathogens: status quo and global trends","volume":"39","author":"Koluman","year":"2013","journal-title":"Crit Rev Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib112","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1473-3099(09)70115-X","article-title":"US supermarkets redefine antibiotic misuse","volume":"9","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib113","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4315\/0362-028X.JFP-11-320","article-title":"Escherichia coli producing cmy-2 beta-lactamase in bovine mastitis milk","volume":"75","author":"Endimiani","year":"2012","journal-title":"J\u00a0Food Prot"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib114","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1128\/AAC.01361-09","article-title":"High diversity of extended-spectrum beta-lactamases in Escherichia coli isolates from Italian broiler flocks","volume":"54","author":"Bortolaia","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib115","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/cid\/cis929","article-title":"Extended-spectrum beta-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors","volume":"56","author":"Kluytmans","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2016.02.003_bib116","doi-asserted-by":"crossref","first-page":"E256","DOI":"10.1111\/1469-0691.12150","article-title":"Prevalence of extended-spectrum beta-lactamase-producing enterobacteriaceae in humans living in municipalities with high and low broiler density","volume":"19","author":"Huijbers","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.idc.2016.02.003_bib117","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1469-0691.2011.03497.x","article-title":"Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains","volume":"17","author":"Leverstein-van Hall","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib118","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/jac\/dkl048","article-title":"First description of an oxyimino-cephalosporin-resistant, ESBL-carrying Escherichia coli isolated from meat sold in Denmark","volume":"57","author":"Jensen","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.idc.2016.02.003_bib119","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1128\/JCM.43.7.3453-3456.2005","article-title":"Repeated occurrence of diverse extended-spectrum beta-lactamases in minor serotypes of food-borne salmonella enterica subsp. enterica","volume":"43","author":"Politi","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"issue":"9","key":"10.1016\/j.idc.2016.02.003_bib120","doi-asserted-by":"crossref","first-page":"e74323","DOI":"10.1371\/journal.pone.0074323","article-title":"Risk factors associated with the community-acquired colonization of extended-spectrum beta-lactamase (ESBL) positive Escherichia coli. An exploratory case-control study","volume":"8","author":"Leistner","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib121","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.04.20065-en","article-title":"Outbreak of haemolytic uraemic syndrome due to shiga toxin-producing Escherichia coli o104:H4 among French tourists returning from turkey, September 2011","volume":"17","author":"Jourdan-da Silva","year":"2012","journal-title":"Euro Surveill"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib122","doi-asserted-by":"crossref","first-page":"e55278","DOI":"10.1371\/journal.pone.0055278","article-title":"Symptoms and clinical course of EHEC o104 infection in hospitalized patients: a prospective single center study","volume":"8","author":"Ullrich","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.idc.2016.02.003_bib123","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1111\/j.1462-2920.2011.02604.x","article-title":"EHEC\/EAEC o104:H4 strain linked with the 2011 German outbreak of haemolytic uremic syndrome enters into the viable but non-culturable state in response to various stresses and resuscitates upon stress relief","volume":"13","author":"Aurass","year":"2011","journal-title":"Environ Microbiol"},{"issue":"3\u20134","key":"10.1016\/j.idc.2016.02.003_bib124","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.vetmic.2009.03.029","article-title":"Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolates in faecal samples of broilers","volume":"138","author":"Costa","year":"2009","journal-title":"Vet Microbiol"},{"issue":"12","key":"10.1016\/j.idc.2016.02.003_bib125","doi-asserted-by":"crossref","first-page":"e53039","DOI":"10.1371\/journal.pone.0053039","article-title":"Comparable high rates of extended-spectrum-beta-lactamase-producing Escherichia coli in birds of prey from Germany and Mongolia","volume":"7","author":"Guenther","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.idc.2016.02.003_bib126","doi-asserted-by":"crossref","first-page":"e50331","DOI":"10.1371\/journal.pone.0050331","article-title":"Frequent combination of antimicrobial multiresistance and extraintestinal pathogenicity in Escherichia coli isolates from urban rats (Rattus norvegicus) in Berlin, Germany","volume":"7","author":"Guenther","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib127","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1758-2229.2010.00148.x","article-title":"Ctx-m-15-type extended-spectrum beta-lactamases-producing Escherichia coli from wild birds in Germany","volume":"2","author":"Guenther","year":"2010","journal-title":"Environ Microbiol Rep"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1292\/jvms.11-0372","article-title":"Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in food-producing animals","volume":"74","author":"Hiroi","year":"2012","journal-title":"J\u00a0Vet Med Sci"},{"issue":"9","key":"10.1016\/j.idc.2016.02.003_bib129","doi-asserted-by":"crossref","first-page":"e73947","DOI":"10.1371\/journal.pone.0073947","article-title":"Dissemination and characterization of plasmids carrying oqxab-bla ctx-m genes in Escherichia coli isolates from food-producing animals","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2016.02.003_bib130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fmicb.2013.00242","article-title":"High prevalence of fecal carriage of extended spectrum beta-lactamase\/AmpC-producing enterobacteriaceae in cats and dogs","volume":"4","author":"Hordijk","year":"2013","journal-title":"Front Microbiol"},{"issue":"3\u20134","key":"10.1016\/j.idc.2016.02.003_bib131","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.vetmic.2010.03.019","article-title":"Increased detection of extended spectrum beta-lactamase producing salmonella enterica and Escherichia coli isolates from poultry","volume":"145","author":"Dierikx","year":"2010","journal-title":"Vet Microbiol"},{"issue":"7","key":"10.1016\/j.idc.2016.02.003_bib132","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3201\/eid1707.110209","article-title":"Extended-spectrum beta-lactamase genes of Escherichia coli in chicken meat and humans, the Netherlands","volume":"17","author":"Overdevest","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib133","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1469-0691.2010.03260.x","article-title":"Transmissibility of livestock-associated methicillin-resistant staphylococcus aureus (st398) in Dutch hospitals","volume":"17","author":"Wassenberg","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.idc.2016.02.003_bib134","first-page":"441","article-title":"Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel","volume":"57","author":"Laupland","year":"2008","journal-title":"J\u00a0Infect"},{"issue":"11","key":"10.1016\/j.idc.2016.02.003_bib135","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1128\/AAC.00576-07","article-title":"First report of the emergence of ctx-m-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system","volume":"51","author":"Lewis","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.idc.2016.02.003_bib136","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/AAC.47.7.2382-2383.2003","article-title":"Discovery of ctx-m-like extended-spectrum beta-lactamases in Escherichia coli isolates from five US states","volume":"47","author":"Moland","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib137","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jac\/dkm464","article-title":"Intercontinental emergence of Escherichia coli clone o25:H4-st131 producing ctx-m-15","volume":"61","author":"Nicolas-Chanoine","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib138","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3201\/eid1402.070350","article-title":"Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase ctx-m-15","volume":"14","author":"Coque","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib139","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/649537","article-title":"Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis","volume":"50","author":"Rodriguez-Bano","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2016.02.003_bib140","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1128\/JCM.00640-08","article-title":"European emergence of ciprofloxacin-resistant Escherichia coli clonal groups o25:H4-st 131 and o15:K52:H1 causing community-acquired uncomplicated cystitis","volume":"46","author":"Cagnacci","year":"2008","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.idc.2016.02.003_bib141","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1128\/JCM.02065-07","article-title":"Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing","volume":"46","author":"Lau","year":"2008","journal-title":"J\u00a0Clin Microbiol"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib142","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijantimicag.2013.06.017","article-title":"Emergence of new variants of st131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum beta-lactamases","volume":"42","author":"Dahbi","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib143","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijantimicag.2009.11.003","article-title":"Molecular epidemiology of Escherichia coli producing ctx-m beta-lactamases: the worldwide emergence of clone st131 o25:H4","volume":"35","author":"Peirano","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"10.1016\/j.idc.2016.02.003_bib144","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1128\/AEM.66.10.4555-4558.2000","article-title":"Rapid and simple determination of the Escherichia coli phylogenetic group","volume":"66","author":"Clermont","year":"2000","journal-title":"Appl Environ Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib145","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.diagmicrobio.2006.08.007","article-title":"Determination of Escherichia coli o types by allele-specific polymerase chain reaction: application to the o types involved in human septicemia","volume":"57","author":"Clermont","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2016.02.003_bib146","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/AAC.00247-09","article-title":"Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary health region from 2000 to 2007: emergence of clone st131 as a cause of community-acquired infections","volume":"53","author":"Pitout","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkq415","article-title":"Escherichia coli o25b-st131: a pandemic, multiresistant, community-associated strain","volume":"66","author":"Rogers","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"15","key":"10.1016\/j.idc.2016.02.003_bib148","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1073\/pnas.1322678111","article-title":"Global dissemination of a multidrug resistant Escherichia coli clone","volume":"111","author":"Petty","year":"2014","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"3","key":"10.1016\/j.idc.2016.02.003_bib149","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/jac\/dkt405","article-title":"Escherichia coli belonging to the worldwide emerging epidemic clonal group o25b\/st131: risk factors and clinical implications","volume":"69","author":"Lopez-Cerero","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.idc.2016.02.003_bib150","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1128\/AAC.00270-15","article-title":"Clinical epidemiology and molecular analysis of extended-spectrum-beta-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648","volume":"59","author":"Sherchan","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.idc.2016.02.003_bib151","doi-asserted-by":"crossref","first-page":"e51147","DOI":"10.1371\/journal.pone.0051147","article-title":"A\u00a0sustainable strategy to prevent misuse of antibiotics for acute respiratory infections","volume":"7","author":"Rattinger","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib152","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ajic.2006.09.011","article-title":"How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition","volume":"35","author":"Harris","year":"2007","journal-title":"Am J Infect Control"},{"issue":"11","key":"10.1016\/j.idc.2016.02.003_bib153","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1128\/AAC.47.11.3506-3514.2003","article-title":"Extended-spectrum beta-lactamase-producing enterobacteriaceae in community and private health care centers","volume":"47","author":"Arpin","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.idc.2016.02.003_bib154","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1128\/JCM.43.10.5048-5054.2005","article-title":"Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing Enterobacteria in the community setting","volume":"43","author":"Arpin","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.idc.2016.02.003_bib155","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/JCM.42.3.1089-1094.2004","article-title":"Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients","volume":"42","author":"Rodriguez-Bano","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"issue":"9","key":"10.1016\/j.idc.2016.02.003_bib156","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1086\/671725","article-title":"Predictors and molecular epidemiology of community-onset extended-spectrum beta-lactamase-producing Escherichia coli infection in a Midwestern community","volume":"34","author":"Banerjee","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"10.1016\/j.idc.2016.02.003_bib157","doi-asserted-by":"crossref","first-page":"e69581","DOI":"10.1371\/journal.pone.0069581","article-title":"Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae\u2013a case-control study in a low prevalence country","volume":"8","author":"Soraas","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.idc.2016.02.003_bib158","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s10096-011-1540-3","article-title":"Comparative epidemiology of ctx-m-14 and ctx-m-15 producing Escherichia coli: association with distinct demographic groups in the community in New Zealand","volume":"31","author":"Freeman","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2016.02.003_bib159","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1128\/JCM.01008-08","article-title":"High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients","volume":"46","author":"Valverde","year":"2008","journal-title":"J\u00a0Clin Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jhin.2006.05.010","article-title":"Epidemiology of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London","volume":"64","author":"Skippen","year":"2006","journal-title":"J\u00a0Hosp Infect"},{"issue":"3","key":"10.1016\/j.idc.2016.02.003_bib161","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1469-0691.2005.01358.x","article-title":"Risk-factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli among hospitalised patients","volume":"12","author":"Pena","year":"2006","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib162","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jac\/dki180","article-title":"Risk factors associated with extended-spectrum beta-lactamase-producing organisms at a tertiary care hospital","volume":"56","author":"Graffunder","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.idc.2016.02.003_bib163","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care\u2013associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib164","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/sur.2013.9999","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"14","author":"Bratzler","year":"2013","journal-title":"Surg Infect (Larchmt)"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ajic.2012.02.036","article-title":"The carbapenem-resistant enterobacteriaceae score: a bedside score to rule out infection with carbapenem-resistant enterobacteriaceae among hospitalized patients","volume":"41","author":"Martin","year":"2013","journal-title":"Am J Infect Control"},{"issue":"8","key":"10.1016\/j.idc.2016.02.003_bib166","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/666642","article-title":"Recent exposure to antimicrobials and carbapenem-resistant enterobacteriaceae: the role of antimicrobial stewardship","volume":"33","author":"Marchaim","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"11","key":"10.1016\/j.idc.2016.02.003_bib167","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10096-007-0371-8","article-title":"Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes","volume":"26","author":"Abbo","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib168","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/345476","article-title":"Comparison of mortality associated with methicillin-resistant and methicillin-susceptible staphylococcus aureus bacteremia: a meta-analysis","volume":"36","author":"Cosgrove","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib169","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/AAC.50.1.43-48.2006","article-title":"Multidrug-resistant pseudomonas aeruginosa: risk factors and clinical impact","volume":"50","author":"Aloush","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"20","key":"10.1016\/j.idc.2016.02.003_bib170","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/archinte.159.20.2461","article-title":"The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis","volume":"159","author":"Carmeli","year":"1999","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.idc.2016.02.003_bib171","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ajic.2014.02.013","article-title":"Outcomes of carbapenem-resistant enterobacteriaceae isolation: matched analysis","volume":"42","author":"Bogan","year":"2014","journal-title":"Am J Infect Control"},{"issue":"11","key":"10.1016\/j.idc.2016.02.003_bib172","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1086\/379321","article-title":"Is methicillin-resistant staphylococcus aureus more virulent than methicillin-susceptible s. Aureus? a comparative cohort study of British patients with nosocomial infection and bacteremia","volume":"37","author":"Melzer","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2016.02.003_bib173","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1128\/AAC.00010-08","article-title":"Extended-spectrum beta-lactamase production is associated with an increase in cell invasion and expression of fimbrial adhesins in Klebsiella pneumoniae","volume":"52","author":"Sahly","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib174","first-page":"27","article-title":"Outcome of bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli: impact of microbiological determinants","volume":"67","author":"Rodriguez-Bano","year":"2013","journal-title":"J\u00a0Infect"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib175","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1128\/AAC.05650-11","article-title":"Clinical and microbiologic characteristics of cephalosporin-resistant Escherichia coli at three centers in the United States","volume":"56","author":"Park","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.idc.2016.02.003_bib176","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1128\/AAC.00533-09","article-title":"Molecular epidemiology of ctx-m-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania","volume":"53","author":"Sidjabat","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.idc.2016.02.003_bib177","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3201\/eid1307.070094","article-title":"Community-acquired extended-spectrum beta-lactamase producers, united states","volume":"13","author":"Doi","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2016.02.003_bib178","doi-asserted-by":"crossref","first-page":"925","DOI":"10.7326\/0003-4819-132-11-200006060-00024","article-title":"Control group selection is an important but neglected issue in studies of antibiotic resistance","volume":"132","author":"Harris","year":"2000","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib179","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/502550","article-title":"The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance","volume":"26","author":"Kaye","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib180","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1586\/14787210.6.5.671","article-title":"Clinical significance of extended-spectrum beta-lactamases","volume":"6","author":"Rodriguez-Bano","year":"2008","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"6","key":"10.1016\/j.idc.2016.02.003_bib181","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1128\/AAC.01509-06","article-title":"Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing enterobacteriaceae: importance of inadequate initial antimicrobial treatment","volume":"51","author":"Tumbarello","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib182","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/AAC.50.2.498-504.2006","article-title":"Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome","volume":"50","author":"Tumbarello","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.idc.2016.02.003_bib183","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1128\/AAC.00627-10","article-title":"Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis","volume":"54","author":"Paul","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.idc.2016.02.003_bib184","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.idc.2016.02.003_bib185","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/AAC.00009-11","article-title":"Identifying patients harboring extended-spectrum-beta-lactamase-producing enterobacteriaceae on hospital admission: derivation and validation of a scoring system","volume":"55","author":"Tumbarello","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.idc.2016.02.003_bib186","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1128\/AAC.01298-09","article-title":"Evaluation of a DNA microarray, the check-points ESBL\/KPC array, for rapid detection of TEM, SHV, and ctx-m extended-spectrum beta-lactamases and KPC carbapenemases","volume":"54","author":"Naas","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.idc.2016.02.003_bib187","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/1469-0691.12729","article-title":"Rapid detection of enterobacteriaceae producing extended spectrum beta-lactamases directly from positive blood cultures by matrix-assisted laser desorption ionization-time of flight mass spectrometry","volume":"20","author":"Oviano","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib188","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1086\/669858","article-title":"Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum beta-lactamase-producing enterobacteriaceae on hospital admission","volume":"34","author":"Johnson","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2016.02.003_bib189","article-title":"Developing a score to shorten the time to initiation of appropriate therapy for extensively drug resistant gram-negative bacilli and avoid unnecessary use of polymixins","author":"Vitkon-Barkay","year":"2014"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/420816","article-title":"Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases","volume":"39","author":"Paterson","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2016.02.003_bib191","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dks301","article-title":"Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to enterobacteriaceae producing extended-spectrum beta-lactamases: a systematic review and meta-analysis","volume":"67","author":"Vardakas","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.idc.2016.02.003_bib192","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.diagmicrobio.2011.03.009","article-title":"The effects of group 1 versus group 2 carbapenems on imipenem-resistant pseudomonas aeruginosa: an ecological study","volume":"70","author":"Carmeli","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib193","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008","volume":"36","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2016.02.003_bib194","article-title":"Ertapenem for the treatment of bloodstream infections due to esbl-producing enterobacteriaceae: A multinational pre-registered cohort study","author":"Gutierrez-Gutierrez","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"24","key":"10.1016\/j.idc.2016.02.003_bib195","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1001\/jama.2008.896","article-title":"Carbapenem-resistant enterobacteriaceae: a potential threat","volume":"300","author":"Schwaber","year":"2008","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.idc.2016.02.003_bib196","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/cid\/cir025","article-title":"Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention","volume":"52","author":"Schwaber","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib197","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.diagmicrobio.2006.06.015","article-title":"Outcome of cephalosporin treatment of bacteremia due to ctx-m-type extended-spectrum beta-lactamase-producing Escherichia coli","volume":"56","author":"Bin","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2016.02.003_bib198","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/JCM.39.6.2206-2212.2001","article-title":"Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory","volume":"39","author":"Paterson","year":"2001","journal-title":"J\u00a0Clin Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib199","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1086\/324742","article-title":"Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime","volume":"34","author":"Wong-Beringer","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2016.02.003_bib200","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1128\/AAC.48.12.4574-4581.2004","article-title":"Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy","volume":"48","author":"Kang","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2016.02.003_bib201","series-title":"Nineteenth informational supplement. Approved standard m100\u2013s20","article-title":"Performance standards for\u00a0antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2010"},{"issue":"7","key":"10.1016\/j.idc.2016.02.003_bib202","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/jac\/dks088","article-title":"Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?","volume":"67","author":"Livermore","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib203","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1086\/380645","article-title":"Bacteremia due to Klebsiella pneumoniae isolates producing the tem-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin","volume":"38","author":"Endimiani","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib204","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/jac\/dks377","article-title":"Contribution of oqxab efflux pumps to quinolone resistance in extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae","volume":"68","author":"Rodriguez-Martinez","year":"2013","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.idc.2016.02.003_bib205","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/jac\/dkr116","article-title":"Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study","volume":"66","author":"Kritsotakis","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib206","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/jac\/dkl381","article-title":"Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates","volume":"58","author":"Lee","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib207","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1469-0691.2009.02893.x","article-title":"Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates","volume":"16","author":"Lopez-Cerero","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.idc.2016.02.003_bib208","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1128\/AAC.45.12.3548-3554.2001","article-title":"Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing enterobacteriaceae","volume":"45","author":"Thomson","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2016.02.003_bib209","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1128\/AAC.00218-06","article-title":"Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility","volume":"50","author":"Zimhony","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib210","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/cir790","article-title":"Beta-lactam\/beta-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts","volume":"54","author":"Rodriguez-Bano","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib211","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/cid\/cir793","article-title":"Can we really use ss-lactam\/ss-lactam inhibitor combinations for the treatment of infections caused by extended-spectrum ss-lactamase-producing bacteria?","volume":"54","author":"Perez","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib212","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1469-0691.2009.03018.x","article-title":"Emergence of ctx-m-15 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in Bosnia and Herzegovina","volume":"16","author":"Dedeic-Ljubovic","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.idc.2016.02.003_bib213","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1034\/j.1399-0012.1999.130305.x","article-title":"A\u00a0randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients","volume":"13","author":"Pfundstein","year":"1999","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.idc.2016.02.003_bib214","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/0003-4975(93)90355-L","article-title":"Antibiotic prophylaxis in cardiac operations","volume":"56","author":"Hall","year":"1993","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.idc.2016.02.003_bib215","first-page":"14","article-title":"Isolation of extended spectrum beta-lactamase (ESBL) producing bacteria from urban surface waters in Malaysia","volume":"20","author":"Tissera","year":"2013","journal-title":"Malays J Med Sci"},{"issue":"8","key":"10.1016\/j.idc.2016.02.003_bib216","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1017\/ice.2015.101","article-title":"Carbapenems versus piperacillin-tazobactam for bloodstream infections of nonurinary source caused by extended-spectrum beta-lactamase-producing enterobacteriaceae","volume":"36","author":"Ofer-Friedman","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"10.1016\/j.idc.2016.02.003_bib217","first-page":"1319","article-title":"Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum beta-lactamase bacteremia","volume":"60","author":"Tamma","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"Suppl","key":"10.1016\/j.idc.2016.02.003_bib218","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0924-8579(12)70008-0","article-title":"Epidemiology and antimicrobial susceptibility profiles of gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the study for monitoring antimicrobial resistance trends (SMART)","volume":"40","author":"Lu","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.idc.2016.02.003_bib219","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1469-0691.2011.03550.x","article-title":"Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum beta-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008-2009)","volume":"18","author":"Hawser","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.idc.2016.02.003_bib220","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/AAC.01808-09","article-title":"Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the study for monitoring antimicrobial resistance trends (SMART)","volume":"54","author":"Hoban","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"6 Pt 2","key":"10.1016\/j.idc.2016.02.003_bib221","first-page":"64S","article-title":"Pharmacodynamic factors of antibiotic efficacy","volume":"12","author":"Rotschafer","year":"1992","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib222","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"20","key":"10.1016\/j.idc.2016.02.003_bib223","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1001\/archinte.168.20.2254","article-title":"Trends in antibacterial use in US academic health centers: 2002 to 2006","volume":"168","author":"Pakyz","year":"2008","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib224","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/clinids\/3.1.74","article-title":"Comparative studies of intermittent and continuous administration of aminoglycosides in the treatment of bronchopulmonary infections due to gram-negative bacteria","volume":"3","author":"Klastersky","year":"1981","journal-title":"Rev Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2016.02.003_bib225","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijantimicag.2009.10.019","article-title":"Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) enterobacteriaceae isolates to fosfomycin","volume":"35","author":"Falagas","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.idc.2016.02.003_bib226","series-title":"Drug safety communication - increased risk of death with tygacil (tigecycline) compared to other antibiotics used to treat similar infections","author":"FDA","year":"2010"},{"issue":"9","key":"10.1016\/j.idc.2016.02.003_bib227","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/cid\/cir611","article-title":"Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system","volume":"53","author":"Pogue","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2016.02.003_bib228","first-page":"1304","article-title":"Editorial commentary: polymyxin-resistant Acinetobacter baumannii: urgent action needed","volume":"60","author":"Pogue","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2016.02.003_bib229","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jmii.2013.07.011","article-title":"Drug susceptibility and treatment response of common urinary tract infection pathogens in children","volume":"47","author":"Chen","year":"2014","journal-title":"J\u00a0Microbiol Immunol Infect"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib230","first-page":"CR246","article-title":"Antibiotic resistance in community-acquired urinary tract infections: prevalence and risk factors","volume":"16","author":"Kurtaran","year":"2010","journal-title":"Med Sci Monit"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib231","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1442-2042.2010.02500.x","article-title":"Current therapy of acute uncomplicated cystitis","volume":"17","author":"Yamamoto","year":"2010","journal-title":"Int J Urol"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2016.02.003_bib232","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ijantimicag.2007.07.043","article-title":"Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2006","volume":"31","author":"Kim","year":"2008","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"10.1016\/j.idc.2016.02.003_bib233","doi-asserted-by":"crossref","first-page":"CR355","DOI":"10.12659\/MSM.881845","article-title":"Changes in bacterial resistance patterns in children with urinary tract infections on antimicrobial prophylaxis at university hospital in split","volume":"17","author":"Ilic","year":"2011","journal-title":"Med Sci Monit"},{"issue":"7","key":"10.1016\/j.idc.2016.02.003_bib234","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1128\/AAC.00260-12","article-title":"Decreased susceptibility to noncarbapenem antimicrobials in extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Toronto, Canada","volume":"56","author":"Lowe","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2016.02.003_bib235","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.diagmicrobio.2005.08.018","article-title":"In\u00a0vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli","volume":"54","author":"Puerto","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2016.02.003_bib236","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/AAC.50.1.368-370.2006","article-title":"In\u00a0vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures","volume":"50","author":"de Cueto","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2016.02.003_bib237","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/jac\/dki344","article-title":"Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey","volume":"56","author":"Arslan","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552016300095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552016300095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T18:49:46Z","timestamp":1567882186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552016300095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":237,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0891552016300095"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2016.02.003","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Continuing Plague of Extended-spectrum \u03b2-lactamase\u2013producing Enterobacteriaceae Infections","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2016.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}